DHR - Danaher Corp

...

Available for logged in users only.

The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.

• Danaher sees slowing topline growth as pandemic impact wanes
• Danaher Non-GAAP EPS of $2.87 beats by $0.32, revenue of $8.37B beats by $430M
• Danaher Q4 2022 Earnings Preview
• Danaher expects Q4 core revenue growth above previous guidance
• Danaher downgraded to neutral at Credit Suisse on exposure to inventory reductions
• Danaher declares $0.25 dividend
• The $5 trillion fund favorites: 12 stocks mutual and hedge funds love
• Danaher posts Q3 beat after broad-based growth
• Danaher Non-GAAP EPS of $2.56 beats by $0.31, revenue of $7.66B beats by $490M
• Repligen, Bio-Rad, life sciences tool makers down after Sartorius says COVID demand slows
• Danaher Q3 2022 Earnings Preview
• Danaher stock rises 4.5% on revenue growth guidance, plan to spin off segment
• August U.S. healthcare govt grants, clinical trials & NIH outlays increase Y/Y, says Baird
• Danaher Corporation declares $0.25 dividend
• Catalyst watch: Amgen data, Starbucks & Roblox events and Twitter vote on Elon Musk deal
• Third Point says Disney is largest recent addition to its portfolio - Q2 letter
• Dan Loeb's Third Point takes new stakes in Colgate, Antero, exits S&P Global
• Danaher earnings boost other diagnostics, life sciences support companies
• Danaher stock rises as Q2 sales soar beating estimates despite impact on COVID products
• Danaher Non-GAAP EPS of $2.76 beats by $0.42, revenue of $7.75B beats by $460M